Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

/PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies...

Related Keywords

New York ,United States ,Shanghai ,China ,Suzhou ,Jiangsu ,Beijing ,San Diego ,California ,Canada ,France ,Rochester ,Xiaoyu ,Guangdong ,American ,Zhihua Liu ,Genhouse Bio ,Philip Tagari ,Robert Langer ,Viva Bioinnovator ,Anne Clem Whitaker ,Annec Whitaker ,Amberstone Biosciences ,Wenwen Zeng ,Amgen ,Massachusetts Institute Of Technology ,Harvard Medical School ,American Diabetes Association ,Viva Biotech Holdings ,Quralis Corporation ,Rochester Ophthalmological Group ,Harvard University ,Institute Of Immunology At Tsinghua University ,Vivavision Biotech Inc ,Viva Biotech ,Innovative Biotech ,Tsinghua University Reached ,Strategic Collaboration Agreement ,New Drugs ,Tsinghua University ,Executive Director ,Professors Zhihua Liu ,Drug Evaluation ,First Patient ,Vivavision Biotech ,Domain Therapeutics ,Biosciences Announces Formation ,Scientific Advisory ,Tumor Microenvironment Activated Therapeutics ,Massachusetts Institute ,Pharma Provides Updates ,Two Lead ,Anji Pharma ,Digestive Disease Week ,Scientific Sessions ,Alis Announces ,Suzhou Industry ,Ocular Hypertension ,